Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Prostatic Neoplasms 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1Leukemia 1Congenital Abnormalities 1Blast Crisis 1

Interventions

fludarabine phosphate 16Peripheral Blood Stem Cell Transplantation 16Cyclophosphamide 16Mycophenolic Acid 14Whole-Body Irradiation 13Cyclosporine 12Busulfan 12Tacrolimus 11Methotrexate 10Antilymphocyte Serum 9Etoposide 7Cyclosporins 7Melphalan 6Sirolimus 5Radiotherapy 5Cytarabine 5Filgrastim 4Cord Blood Stem Cell Transplantation 4ruxolitinib 3Rituximab 3Granulocyte Colony-Stimulating Factor 3Alemtuzumab 3thymoglobulin 2sargramostim 2Pentostatin 2Methylprednisolone 2Flow Cytometry 2Carmustine 2Carboplatin 2veliparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Myelodysplastic-Myeloproliferative Diseases × treosulfan × Clear all
NCT01894477 2021-06-03

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Fred Hutchinson Cancer Center

Phase 2 Unknown
102 enrolled 12 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡